Functional Imaging of Social Cognition in Premanifest Huntington's Disease (FISCIP)
Primary Purpose
Huntington's Disease
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
functional Imaging
Sponsored by
About this trial
This is an interventional basic science trial for Huntington's Disease
Eligibility Criteria
Inclusion Criteria:
- Huntington's disease positive genotype and non-carrier siblings
Exclusion Criteria:
- visible chorea
- MRI contra-indications
- major neurological/psychiatric comorbidity
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
functional Imaging mutation carrier
functional Imaging non-carrier
Arm Description
Premanifest mutation carrier, behavioral and neural emotional memory processing
non-carrier family member, behavioral and neural emotional memory processing
Outcomes
Primary Outcome Measures
Significant group differences in brain activation for perceiving emotional vs neutral faces by following random effects analyses
Significant group differences in beta-values for the contrast emotional faces vs neutral faces following general linear model parameter estimates
Secondary Outcome Measures
Full Information
NCT ID
NCT02551705
First Posted
September 7, 2015
Last Updated
September 14, 2015
Sponsor
Universitaire Ziekenhuizen KU Leuven
1. Study Identification
Unique Protocol Identification Number
NCT02551705
Brief Title
Functional Imaging of Social Cognition in Premanifest Huntington's Disease
Acronym
FISCIP
Official Title
Functional Imaging of Social Cognition in Premanifest Huntington's Disease
Study Type
Interventional
2. Study Status
Record Verification Date
September 2015
Overall Recruitment Status
Unknown status
Study Start Date
October 2015 (undefined)
Primary Completion Date
October 2017 (Anticipated)
Study Completion Date
October 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitaire Ziekenhuizen KU Leuven
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Huntington's disease (HD) is a genetic progressive fatal neurodegenerative disorder. In the western world it affects 5-10 persons per 100000. The main brain changes include the loss of brain cells in subcortical structures. The symptoms of HD include involuntary movements, cognitive deterioration and behavioural disturbances. It has been shown that changes in emotion comprehension occur before the onset of the motor symptoms (preHD). This deficit in perception of emotions has been primarily investigated by means of facial expressions. However, emotions can also be expressed through body language. Here, the investigators propose to investigate whether the emotion comprehension deficit in preHD also includes body language comprehension.
Detailed Description
The investigators will perform a detailed evaluation of body language comprehension abilities in persons that carry the genetic mutation causing HD, but who do not show any movement symptoms yet. In addition, the associated changes in brain structure and function will be studied. The aim is to perform the study with the same group of participants who participated in a recent study carried on by this research group, in which the functional brain changes associated with increased irritability were investigated. This will allow to relate emotion experience with emotion perception. The results of the study may provide a target to further develop therapeutic interventions and aid caregivers of preHD subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Huntington's Disease
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Investigator
Allocation
Non-Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
functional Imaging mutation carrier
Arm Type
Experimental
Arm Description
Premanifest mutation carrier, behavioral and neural emotional memory processing
Arm Title
functional Imaging non-carrier
Arm Type
Active Comparator
Arm Description
non-carrier family member, behavioral and neural emotional memory processing
Intervention Type
Other
Intervention Name(s)
functional Imaging
Intervention Description
Brain responses associated with emotional memory will be investigated
Primary Outcome Measure Information:
Title
Significant group differences in brain activation for perceiving emotional vs neutral faces by following random effects analyses
Description
Significant group differences in beta-values for the contrast emotional faces vs neutral faces following general linear model parameter estimates
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Huntington's disease positive genotype and non-carrier siblings
Exclusion Criteria:
visible chorea
MRI contra-indications
major neurological/psychiatric comorbidity
12. IPD Sharing Statement
Learn more about this trial
Functional Imaging of Social Cognition in Premanifest Huntington's Disease
We'll reach out to this number within 24 hrs